Integrating neurobiology and psychopathology into evidence-based treatment of social anxiety disorder.

CNS spectrums

Volumn 10, Issue 10, 2005, Pages

  Liebowitz, Michael R ^a   Ninan, Philip T ^a   Schneier, Franklin R ^a   Blanco, Carlos ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANIMAL; ARTICLE; BRAIN; CHILD; CROSS-SECTIONAL STUDY; DRUG EFFECT; EVIDENCE BASED MEDICINE; HUMAN; INFANT; LONG TERM CARE; PATHOPHYSIOLOGY; PHOBIA; PSYCHOLOGICAL ASPECT; RISK FACTOR; SOCIALIZATION;

ADULT; ANIMALS; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; BRAIN; CHILD; CROSS-SECTIONAL STUDIES; EVIDENCE-BASED MEDICINE; HUMANS; INFANT; LONG-TERM CARE; PHOBIC DISORDERS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SOCIALIZATION;

MLCS; MLOWN;

EID: 33644869630     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900010336     Document Type: Article

References (0)